Neimeth International Pharmaceuticals Plc reported earnings results for the second quarter and six months ended March 31, 2022. For the second quarter, the company reported sales was NGN 793.13 million compared to NGN 887.01 million a year ago. Net income was NGN 100.18 million compared to NGN 207.1 million a year ago. Basic earnings per share from continuing operations was NGN 0.0527 compared to NGN 0.109 a year ago.
For the six months, sales was NGN 985.25 million compared to NGN 1,281.58 million a year ago. Net loss was NGN 208.93 million compared to net income of NGN 28.31 million a year ago. Basic loss per share from continuing operations was NGN 0.11 compared to basic earnings per share from continuing operations of NGN 0.0149 a year ago.